What Can Autism Genetic Testing Tell My Family?

Which genetic tests are usually offered after an autism diagnosis?

The usual tests look at different parts of the genetic picture, so a genetics team can recommend more than one. Testing is optional, and no single test detects every genetic condition, according to the American Academy of Pediatrics.

Chromosomal microarray looks for missing or extra pieces of chromosomes. Autism Speaks reports that it finds a genetic variation likely accounting for autism in about 3% to 10% of people tested.

Fragile X testing is separate. Fragile X cannot be found by microarray or exome sequencing, so one test does not replace the other.

Exome sequencing examines the coding DNA across about 20,000 genes. Autism Speaks estimates that it identifies a potential cause in about 10% to 30% of cases, with a higher likelihood when intellectual disability is present. For children with congenital anomalies, developmental delay, or intellectual disability, the American College of Medical Genetics and Genomics strongly recommends exome or genome sequencing as a first- or second-tier test. Its guideline does not cover isolated autism without those features.

Tests answer different questions. A broad test is not a complete test.

Can a genetic test explain why my child is autistic?

It can identify a known genetic change linked to autism, yet it often cannot name one complete cause. The U.S. National Library of Medicine’s MedlinePlus Genetics estimates that genetic factors contribute 40% to 80% of autism spectrum disorder risk. It also reports more than 1,000 genes associated with ASD, though many reported links remain unconfirmed and most common variants have small individual effects.

Rare gene mutations or chromosome abnormalities are thought to cause autism in about 2% to 4% of people with ASD, often within a syndrome that includes other health features. A genetic result therefore can give a family a useful name for a pattern of care. It does not turn autism into a simple one-gene story.

A pathogenic variant is a change known to affect health. It can confirm a diagnosis, identify risk, lead to further testing, or shape medical follow-up. A known finding can prompt screening for related health conditions or a referral to another specialist. Autism Speaks uses PTEN-associated cancer risk as an example.

A variant of uncertain significance, or VUS, is different. The MedlinePlus guide to genetic test results states that a VUS cannot confirm or rule out a diagnosis or determine increased risk because the evidence is insufficient or conflicting. It is a question mark, not a verdict.

Testing relatives can sometimes help answer that question. An affected or unaffected parent, sibling, or other relative can show whether a VUS tracks with a condition in the family. A genetic counselor can explain whether that extra information is useful before anyone agrees to testing.

One test result also does not settle every family decision. A diagnosis can inform conversations about relatives, reproductive planning, medical monitoring, services, or research participation. It cannot dictate any of them. For a separate plain-language look at the limits of consumer genetic claims, see Can a DNA Diet Test Tell Me Which Diet Is Best for Me?.

What does a negative autism genetic test result mean?

A negative result means the laboratory did not find a known health-affecting change in the part of the genome it tested. It does not mean autism has no genetic component, and it does not rule out a genetic condition.

MedlinePlus states that tests can miss disease-causing changes because many tests cannot detect every alteration that can cause a disorder. Medical knowledge also changes. HealthyChildren.org says an inconclusive or negative result can warrant follow-up in a few years as testing improves.

This is the hard distinction: negative means no answer from that test today. It does not mean no answer exists.

A nondiagnostic result can still narrow the field. The ACMG guideline reports that such results can make some conditions with prognostic implications, including increased risks of seizures, cancer, or vision loss, less likely. That finding comes from evidence on children with congenital anomalies, developmental delay, or intellectual disability, not isolated autism alone.

Bring the report to a genetics visit. Ask which test was used, what it can miss, whether reanalysis is available, whether a VUS needs family testing, and whether any findings change screening or referrals. Ask about turnaround time and prior authorization before testing as well. HealthyChildren.org reports result timing can range from 2 to 3 weeks to 4 to 8 weeks or longer.

Privacy belongs in the same conversation. The National Human Genome Research Institute explains that the 2008 Genetic Information Nondiscrimination Act bars health insurers from using genetic information for eligibility, coverage, underwriting, or premiums, and bars covered employers from using it in employment decisions. GINA does not cover life, disability, or long-term-care insurance. State laws can add protections.